ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,128, issued on Dec. 2, was assigned to Navad Life Sciences PTE Ltd. (City House, Singapore).
"Progestogen-only oral contraception" was invented by Michael Oettel (Jena, Germany), Hermann Osterwald (Badenweiler, Germany) and Prithi S. Kochhar (New Delhi).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method for providing progestogen only contraception."
The patent was filed on May 22, 2023, under Application No. 18/200,152.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12485128&OS...